Data / Form D filings / HORIZON PHARMA, INC.
HORIZON PHARMA, INC.: Form D filings
HORIZON PHARMA, INC., a pharmaceuticals company in Deerfield, IL, filed 8 Form D notices with the SEC between 2010 and 2013. The latest, on December 9, 2013, reports $150 million sold of a $150 million offering to 74 investors.
Find out what HORIZON PHARMA, INC. does, who founded it and who invested, beyond what the filing says. $10 of credit on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.
Company details from the filing
- Address
- 520 LAKE COOK ROAD, SUITE 520, Deerfield, IL, 60062
- Phone
- (224) 383-3000
- Industry
- Pharmaceuticals
- Entity type
- Corporation
- Incorporated in
- Delaware
- Year incorporated
- 2010
- Revenue range
- Decline to Disclose
- Exemptions claimed
- Rule 506(b)
- SEC identifier (CIK)
- 1492426
The full lists. Form D filings in Illinois: 1,511 rows, $75.55, or the new rows each week for $19 a month. Form D filings in Pharmaceuticals: 346 rows, $17.30, or the new rows each week for $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (company, CIK, street, city, state, ZIP and 4 more), which open on your screen as soon as the payment clears and come by email. For agents and scripts: every list with its row count and price is at https://specstream.ai/data/lists.json.
Form D filings
| Filed | Type | Offering | Sold | Remaining | Investors | First sale | Filing |
|---|---|---|---|---|---|---|---|
| Dec 9, 2013 | New notice | $150,000,000 | $150,000,000 | $0 | 74 | Nov 22, 2013 | sec.gov |
| Mar 19, 2012 | New notice | $65,934,397 | $65,934,397 | $0 | 32 | Mar 2, 2012 | sec.gov |
| Mar 8, 2012 | New notice | $32,772 | $32,772 | $0 | 6 | Feb 22, 2012 | sec.gov |
| Jun 17, 2011 | New notice | $637,500 | $637,500 | $0 | 2 | Jun 2, 2011 | sec.gov |
| May 4, 2011 | Amendment | $37,500,000 | $36,783,085 | $716,915 | 37 | Apr 1, 2010 | sec.gov |
| Jan 21, 2011 | Amendment | $35,500,000 | $35,030,345 | $469,655 | 37 | Apr 1, 2010 | sec.gov |
| May 24, 2010 | New notice | $30,000,000 | $20,000,000 | $10,000,000 | 37 | Apr 1, 2010 | sec.gov |
| May 24, 2010 | New notice | Indefinite | $0 | Indefinite | 68 | Apr 1, 2010 | sec.gov |
Executive officers and directors named in the filing
| Name | Role | Note in the filing |
|---|---|---|
| Ronald W. Pauli | Director | |
| Robert P. De Vaere | Executive Officer | |
| Jeffrey W. Bird | Director | |
| Michael W. Grey | Director | |
| Timothy P. Walbert | Executive Officer, Director | |
| Gino W. Santini | Director | |
| Jean-Francois W. Formela | Director | |
| Jeff P. Himawan | Director |
Every Form D from the week of Dec 9, 2013 · All recent filings in Illinois · All recent Pharmaceuticals filings
Read from SEC EDGAR. Amount sold is what HORIZON PHARMA, INC. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.
$10 of credit on sign-up, no card.